European law on drug precursors
Today, European law on drug precursors has gained great relevance in various areas of society, awakening the interest and attention of many people around the world. Its impact has been so significant that it has generated endless debates, research and analysis about its influence on people's daily lives. Furthermore, European law on drug precursors has been the subject of numerous studies and investigations seeking to understand its true scope and possible long-term implications. In this article, we will explore the phenomenon of European law on drug precursors in depth, analyzing its most relevant aspects and its impact on today's society.
European law on illicit drug precursors:
- Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004 on drug precursors (contains list of substances)
- Council Regulation (EC) No 111/2005 of 22 December 2004 laying down rules for the monitoring of trade between the Union and third countries in drug precursors. Consolidated text (2021) (contains the same list of substances)
- Commission Regulation (EC) No 297/2009 of 8 April 2009 amending Regulation (EC) No 1277/2005 laying down implementing rules for Regulation (EC) No 273/2004 of the European Parliament and of the Council on drug precursors and for Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Community and third countries in drug precursors
The list of 23 substances is identical to list of UN-controlled drug precursors, except for the different categorization and inclusion of stereoisomers in EU Category 1.
List of substances
Category 1 Precursors
- phenylacetone
- methyl 2-phenylacetoacetate (MAPA)
- methyl 2-methyl-3-phenyloxirane-2-carboxylate (BMK methyl glycidate)
- 2-methyl-3-phenyloxirane-2-carboxylic acid (BMK glycidic acid)
- N-acetylanthranilic acid
- alpha-phenylacetoacetamide (APAA)
- alpha-phenylacetoacetonitrile (APAAN)
- isosafrole (cis + trans)
- 3,4-methylenedioxyphenylpropan-2-one
- piperonal
- safrole
- methyl 3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylate (PMK methyl glycidate)
- 3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylic acid (PMK glycidic acid)
- 4-anilino-N-phenethylpiperidine (ANPP)
- N-phenethyl-4-piperidone (NPP)
- ephedrine
- chloroephedrine
- pseudoephedrine
- chloropseudoephedrine
- norephedrine
- ergometrine
- ergotamine
- lysergic acid
The stereoisomeric forms of the substances listed in this Category not being cathine, whenever the existence of such forms is possible.
The salts of the substances listed in this Category whenever the existence of such salts is possible and not being the salts of cathine.
Category 2 Precursors
- red phosphorus
- acetic anhydride
- phenylacetic acid
- anthranilic acid
- piperidine
- potassium permanganate
The salts of the substances listed in this Category whenever the existence of such salts is possible.
Category 3 Precursors
- hydrochloric acid (hydrogen chloride)
- sulphuric acid
- toluene
- diethyl ether
- acetone
- methylethylketone
The salts of the substances listed in this Category whenever the existence of such salts is possible and not being the salts of hydrochloric acid and sulphuric acid.
Category 4 Precursors
- Medicinal products and veterinary medicinal products containing ephedrine or its salts
- Medicinal products and veterinary medicinal products containing pseudo-ephedrine or its salts
See also
- List of UN-controlled drug precursors
- List of US-controlled drug precursors
- Drug precursors
- European Council decisions on designer drugs
- European Monitoring Centre for Drugs and Drug Addiction